Stockwinners Market Radar for March 22, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:22 EDT Iridium CEO: We've doubled our bottom line over the past eight years - In an interview on CNBC's Mad Money, Iridium CEO Matthew Desch said: We have a CapEx holiday... Our free cash flow is poised to expand dramatically over the next ten years... Aireon service will surveil aircraft in real time... Aireon is not just about safety, it's also about efficiency... We're more like a tower REIT as opposed to a satellite company.

17:44 EDT Lawmaker urges FAA, Boeing workers to utilize whistleblower page - Chair of the House Committee on Transportation and Infrastructure Peter DeFazio said in a statement that he is encouraging any current or former officials or employees of Boeing and the Federal Aviation Administration, who are familiar with the FAA's aircraft certification program, to utilize the Committee's whistleblower webpage if they have any information that would be of interest to the Committee and its investigation into the FAA's approach to certifying the Boeing 737 MAX. The website allows anyone to submit information anonymously. "I want to hear from those who may have any information related to the FAA's aircraft certification program, particularly with regards to the certification of the Boeing 737 MAX, and wish to share it confidentially," said DeFazio. "Our Committee has created a whistleblower webpage to serve as a resource for anyone who has information to share, and as we continue investigate this program, we are eager to hear from anyone who can help. It is imperative we continue to ensure we have the highest level of safety for the traveling public." Reference Link

17:35 EDT Onex to acquire Gluskin Sheff - Onex Corporation and Gluskin Sheff + Associates announced they have entered into a definitive agreement under which Onex will acquire 100% of Gluskin Sheff for C$14.25 per share. The purchase price represents a 28% premium to Gluskin Sheff's closing share price on March 22 and a 37% premium to the 60-day volume weighted average price. The total cash consideration for 100% of Gluskin Sheff's equity is approximately C$445M. Gluskin Sheff will continue to be led by its existing leadership team and operate under its brand. The transaction is to be effected by way of a court-approved plan of arrangement and is expected to close in the first half of 2019, subject to receipt of Gluskin Sheff shareholder and court approvals, required regulatory approvals and customary closing conditions.

17:10 EDT Boeing awarded $4.14B Missle Defense Agency contract - Boeing (BA) has been awarded $4.14B, partially definitizing the $6.56B undefinitized contract action, or UCA, issued January 31, 2018, on a ground-based midcourse defense, or GMD, development and sustainment contract, or DSC. The UCA extended the DSC period of performance from January 2018 through December 2023, and added the requirements to execute the GMD portion of the presidential mandated and congressionally enacted Missile Defeat and Defense Enhancements. This effort includes delivery of a new missile field with 20 silos and two additional silos in a previously constructed missile field at Fort Greely, Alaska. The MDA is deferring the production of the 20 additional ground based interceptors, or GBIs, at this time due to the delay associated with not meeting the entrance criteria for the redesigned kill vehicle critical design review. A portion of the effort to deliver 11 boost vehicles for flight tests and spares will remain under the UCA at this time. This modification brings the total cumulative value of the contract, including options, to $10.8B. The definitized scope of work includes technical capabilities to expand and improve a missile defense system to ensure defensive capabilities remain both relevant and current. The definitized effort will be performed by an industry team consisting of Boeing, Northrop Grumman (NOC), Raytheon (RTN) and many other subcontractors. This acquisition was executed on a sole-source basis under the statutory authority of 10 U.S. Code 2304, as implemented by Federal Acquisition Regulation 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements. FY18 and FY19 research, development, test and evaluation funds in the amount of $26.95M were obligated at the time of award. The Missile Defense Agency is the contracting activity.

16:39 EDT Mesoblast names Joseph Swedish as non-executive board chairman - Mesoblast (MESO) announced it has appointed Joseph R. Swedish as non-executive board chairman. Mr Swedish will succeed outgoing Chairman Brian Jamieson, who is retiring from the board on March 31, 2019.

16:32 EDT ADT Inc. announces dividend reinvestment plan - ADT announced that its stockholders will have an opportunity to participate in its Dividend Reinvestment Plan. The company has adopted the Plan to provide stockholders of record on the applicable record date with the opportunity to designate all or a portion of the cash dividends they are entitled to receive on their shares of common stock for reinvestment in additional shares of the company's common stock. Initially, the company will issue the shares under the Plan directly at no discount to the volume weighted average closing trading price per share of the company's common stock for the five trading days preceding the dividend payment date with respect to the common stock and without incurring brokerage fees or commissions. The maximum number of shares of common stock that may be issued under the Plan is 18,750,000 shares and the Plan will be in effect until February 27, 2021 unless earlier suspended or terminated by the board of directors.

16:16 EDT Navios Maritime Partners receives continued listing standards notice from NYSE - Navios Maritime Partners L.P. announced that on March 14, 2019, the company was notified by the New York Stock Exchange, Inc. that it is no longer in compliance with the NYSE's continued listing standards because the average closing price of the company's common stock over a consecutive 30 trading-day period was less than $1.00 per unit. The NYSE's notification has no impact on the company's business operations. The company responded to the NYSE confirming its intent to cure this deficiency within the prescribed timeframe set out in the NYSE's Listed Company Manual. During this time, the company's common stock will continue to be listed and trade on the NYSE. The NYSE's notification does not affect the company's Securities and Exchange Commission reporting requirements.

15:49 EDT Ross Stores CFO sells 9,924 common shares - In a regulatory filing, Ross Stores CFO Michael J. Hartshorn disclosed the sale of 9,924 common shares of the company at a price of $91.4805 per share.

15:37 EDT Recro Pharma CRL from FDA says meloxicam onset fails to meet expectations - Recro Pharma announced it has received a second complete response letter, or CRL, from the FDA Office of Drug Evaluation II regarding their new drug application, or NDA, seeking approval for intravenous, or IV, meloxicam for the management of moderate to severe pain. The FDA's comments in the CRL focused on onset and duration of IV meloxicam, noting that the delayed onset fails to meet the prescriber expectations for IV drugs. The CRL also cited regulatory concerns about the role of IV meloxicam as a monotherapy in acute pain, as well as how it would meet patient and prescriber needs in that setting, given the FDA's interpretation of the clinical trials data. The company strongly disagrees with FDA's interpretation and its views on the clinical utility of IV meloxicam in the acute pain setting. The FDA did not identify any CMC issues in this CRL. Recro intends to continue to pursue regulatory approval for IV meloxicam and will request a meeting with the FDA and work closely with them to resolve these issues.

15:25 EDT Recro Pharma trading halted, news pending

14:45 EDT Lexicon trading resumes

14:23 EDT Lexicon to resume trading at 2:45 pm ET - Lexicon (LXRX) shares are scheduled to resume trading at 2:45 pm ET, according to Nasdaq, with quotation scheduled to resume at 2:40 pm ET. The stock had been halted before the company and partner Sanofi (SNY) announced that the FDA issued a Complete Response Letter regarding the New Drug Application for Zynquista in the treatment of type 1 diabetes.

14:16 EDT Sanofi says FDA issues CRL for Zynquista - The U.S. Food and Drug Administration issued a Complete Response Letter regarding the New Drug Application for investigational Zynquista, a dual SGLT1 and SGLT2 inhibitor for the treatment of adults with type 1 diabetes in combination with insulin. A CRL is a communication from the FDA that informs companies that an application cannot be approved in its present form. Sanofi (SNY) and Lexicon (LXRX) will work closely with the FDA to determine the appropriate next steps.

13:04 EDT Baker Hughes reports U.S. rig count down 10 to 1,016 rigs - Baker Hughes reports that the U.S. rig count is down 10 rigs from last week to 1,016, with oil rigs down 9 to 824 and gas rigs down 1 to 192. The U.S. Rig Count is up 21 rigs from last year's count of 995, with oil rigs up 20, gas rigs up 2, and miscellaneous rigs down 1 to 0. The U.S. Offshore Rig Count is down 2 rigs to 20 and up 7 rigs year-over-year. The Canada Rig Count is down 56 rigs from last week to 105, with oil rigs down 49 to 49 and gas rigs down 7 to 56. The Canada Rig Count is down 56 rigs from last year's count of 161, with oil rigs down 44 and gas rigs down 12.

12:55 EDT Marsh & McLennan reports EC approves Jardine Lloyd Thompson acquisition - Marsh & McLennan announced that the European Commission approved its acquisition of Jardine Lloyd Thompson Group. All regulatory and competition authority approvals required to close the transaction have now been satisfied. A hearing at the UK High Court has been set for March 29, 2019. Subject to the Court's approval, the transaction is expected to close on April 1, the company said.

12:32 EDT Phoenix New Media announces agreement to sell investment in Yidian for $448M - Phoenix New Media Limited announced that it has entered into a share purchase agreement with Run Liang Tai Management Limited to sell 32% of the total outstanding shares of Particle to Run Liang Tai and its designated entities for a total consideration of $448M in cash. The company currently owns approximately 37.63% of the total outstanding shares of Particle on an as-if converted basis and is expected to own approximately 5.63% if the Proposed Transactions are completed. The Proposed Buyers have paid cash deposit of $100M to the company, and the company and the Proposed Buyers entered into the SPA on March 22, the deadline set forth in the LOI. Completion of the Proposed Transactions, however, are still subject to certain closing conditions, including but not limited to approvals by the board of directors and shareholders of the Company's parent company, Phoenix Media Investment, as well as approvals, consents and waivers, as applicable, of other shareholders of Particle. There is no assurance that the Proposed Transactions will ever be closed.

12:08 EDT Merrill Lynch to pay over $8M for improper handling of ADRs - The Securities and Exchange Commission announced that Merrill Lynch, Pierce, Fenner & Smith Incorporated will pay over $8M to settle charges of improper handling of "pre-released" American Depositary Receipts. The SEC's order found that Merrill Lynch improperly borrowed pre-released ADRs from other brokers when Merrill Lynch should have known that those brokers - middlemen who obtained pre-released ADRs from depositaries - did not own the foreign shares needed to support those ADRs. Such practices resulted in inflating the total number of a foreign issuer's tradeable securities, which resulted in abusive practices like inappropriate short selling and dividend arbitrage that should not have been occurring. The order against Merrill Lynch found that its policies, procedures, and supervision failed to prevent and detect securities laws violations concerning borrowing pre-released ADRs from these middlemen. This is the SEC's ninth enforcement action against a bank or broker resulting from its ongoing investigation into abusive ADR pre-release practices, which has thus far resulted in monetary settlements exceeding $370M.

12:00 EDT Zuora falls -15.5% - Zuora is down -15.5%, or -$3.77 to $20.56.

12:00 EDT Small Cap Bear 3x rises 8.5% - Small Cap Bear 3x is up 8.5%, or 81c to $10.30.

12:00 EDT ProShares Trust Ultra VIX Short Term Futures ETF rises 13.3% - ProShares Trust Ultra VIX Short Term Futures ETF is up 13.3%, or $5.07 to $43.20.

10:57 EDT India Globalization Capital launches new website to sell bulk CBD products - India Globalization Capital said via Twitter that it has launched a new website, holihemp.com, to sell its bulk CBD and hemp products. Reference Link

10:50 EDT Nokia says investigation 'not expected to have a material impact' - The company said, "While Nokia does not typically comment on market rumors, given the market reaction and inquiries related to a disclosure in the risk factors section of its annual report on Form 20-F for 2018, the company issues this statement to clarify that the specified investigation is not expected to have a material impact on Nokia. We have seen no evidence that would suggest that criminal penalties would apply in this case, and we believe it is highly likely that any penalties that might apply would be limited and immaterial. Nokia wishes to clarify that the context of this disclosure is the risk factors section of its annual report on Form 20-F where the company lists various risks which could potentially have a material impact on it. However, the disclosure does not reflect Nokia's assessment of the expected or likely impact of the investigation on Nokia. As noted in the annual report, to ensure complete compliance we are now scrutinizing certain transactions in the former Alcatel Lucent business. Out of an abundance of caution and in the spirit of transparency, Nokia has contacted the relevant regulatory authority regarding this review. We are proud of our reputation as one of the world's most ethical companies and this level of openness, transparency and cooperation is what you would expect from Nokia."

10:34 EDT Discovery Communications trading resumes

10:32 EDT Smith says Bristol-Myers bid values Celgene for 10 upcoming blockbusters - Starboard Value's Jeffrey Smith is speaking on CNBC.

10:29 EDT Discovery Communications trading halted, volatility trading pause

10:04 EDT General Motors confirms plans to invest $300M in EV production at Michigan plant - General Motors confirmed that it is investing $300M in its Orion Township, Michigan, assembly plant to produce a new Chevrolet electric vehicle that will bring 400 new jobs to the Orion plant. The new Chevrolet electric vehicle is in addition to the existing Chevrolet Bolt EV and will be designed and engineered off an advanced version of the current Bolt EV architecture. Additional product information and timing for the new Chevrolet EV will be released closer to production. "Today's announcement is part of GM's new commitment to invest a total of $1.8B in its United States manufacturing operations, creating 700 new jobs and supporting 28,000 jobs across six states," the company stated. The new electric vehicle had been slated for production outside of the U.S. but the decision to bring it to Orion was based on factors that include the Orion plant currently builds the Bolt EV and moving production to a U.S. manufacturing plant supports the rules of origin provisions in the proposed United States, Mexico and Canada Agreement, GM said.

10:00 EDT Greenbrier falls -7.8% - Greenbrier is down -7.8%, or -$2.92 to $34.46.

10:00 EDT Vitamin Shoppe rises 4.0% - Vitamin Shoppe is up 4.0%, or 31c to $8.07.

10:00 EDT VelocityShares 3x Inv Natural Gas ETN rises 5.9% - VelocityShares 3x Inv Natural Gas ETN is up 5.9%, or $5.39 to $96.70.

09:52 EDT Chegg drops 2% to $38.68 after Citron puts $25 target on shares

09:28 EDT BlackRock enters agreement to repurchase 3.1M shares - BlackRock entered into an agreement to repurchase approximately 3.1M of its shares at a per share price of $412.84 in a private transaction under its existing repurchase program. The share repurchase transaction is expected to close on March 25, subject to customary closing conditions. As of March 25, BlackRock will have repurchased an aggregate of approximately $1.6B of its shares in 2019 and will have completed its targeted level of share repurchases for the year, but will remain opportunistic should relative valuation opportunities arise.

09:21 EDT PolyMet Mining receives final federal permit for NorthMet project - PolyMet Mining (PLM) announced the U.S. Army Corps of Engineers has issued its Record of Decision and Section 404 wetlands permit for the NorthMet Project. Along with recently issued state permits, PolyMet now holds all necessary permits to construct and operate the NorthMet copper-nickel-precious metals mine and processing plant located near Hoyt Lakes, Minnesota. PolyMet also announced that it has entered into an extension agreement with Glencore (GLNCY) with respect to the approximate $243M in secured convertible and non-convertible debt owing to Glencore which is due to mature on March 31, 2019. Glencore has agreed to extend the maturity date of the debt to provide PolyMet time to prepare for and complete a rights offering by June 30, 2019, fully backstopped by Glencore, to raise sufficient funds to repay the outstanding debt. In connection with the extension agreement, the company has also agreed to issue additional purchase warrants to Glencore and to make certain amendments to the existing exchange warrants held by Glencore, subject to applicable stock exchange approval. The company will provide further information with respect to the pricing and timing of the rights offering in due course.

09:07 EDT Eastside Distilling announces new authorizations to offer whiskey in 200 stores - Eastside Distilling announced new authorizations to offer Redneck Riviera Whiskey in approximately 200 Meijer's stores in the midwestern United States. The authorization calls for the product to be offered in Michigan, Wisconsin, Indiana, Illinois, and Kentucky.

09:05 EDT MoSys granted 180-day extension by Nasdaq to regain compliance - MoSys announced that it received notification from the listing qualifications department of Nasdaq indicating that the company will have an additional 180-day grace period, until September 16, to regain compliance with Nasdaq's $1.00 minimum bid requirement. The notification indicated that the company did not regain compliance during the initial 180-day grace period provided under Nasdaq Rule 5810. In accordance with the rule, the company is eligible for the additional grace period because it meets the initial listing requirements for Nasdaq, except for the bid-price requirement and provided written notice of its intention to cure the deficiency during the additional 180-day grace period by effecting a reverse stock split, if necessary, within ten business days prior to expiration of the grace period. The company can regain compliance by maintaining a minimum closing bid price of $1.00 per share for 10 consecutive business days. If MoSys does not meet the minimum bid requirement during the additional 180-day grace period, Nasdaq will provide written notification to the company that its common stock will be subject to delisting. At such time, the company may appeal the delisting determination. The company would remain listed pending the panel's decision.

09:02 EDT Fly Intel: Pre-market Movers - HIGHER: Denbury Resources (DNR), up 5% after mutually agreeing with Penn Virginia (PVAC) to terminate their previously announced merger agreement... Avon Products (AVP), up 5% after the Wall Street Journal reported the company held talks that included a potential deal that Natura would acquire Avon's North American business... Immutep (IMMP), up 44% after being issued a patent that provides intellectual property protection for the company's method of treating cancer by the administration of a chemotherapy agent and a plurality of doses of eftilagimod alpha... Lumentum (LITE), up 4% after JPMorgan analyst Samik Chatterjee upgraded the stock to Overweight from Neutral and raised his price target for the shares to $65 from $50. UP AFTER EARNINGS: Hibbett Sports (HIBB), up 27%. DOWN AFTER EARNINGS: Nike (NKE), down 4.5%. Shares of Foot Locker (FL), a key Nike distributor, are also down nearly 3%... Tiffany (TIF), down 4%... JinkoSolar (JKS), down 5%... Zuora (ZUO), down 10%. LOWER: Sorrento Therapeutics (SRNE), down 1% after announcing that its 77% owned subsidiary Scilex Pharmaceuticals has closed a transaction to merge with Semnur Pharmaceuticals to form a new company, Scilex Holding... Nokia (NOK), down 6% after Reuters reports Finland's data protection ombudsman said he would investigate whether Nokia-branded phones had breached data rules after a report said the handsets sent information to China. Nokia also revealed yesterday in a filing that it has initiated an internal investigation into compliance issues at the former Alcatel Lucent business.

08:44 EDT EU commercial vehicle registrations up 4.7% in February - In February, the EU market for commercial vehicles continued to grow by 4.7%, according to the European Automobile Manufacturers Association. Registrations increased from 173,492 to 181,636 units, with growth being sustained across all commercial vehicle segments, the group said. Publicly traded truck makers and suppliers include Daimler AG (DDAIF), Paccar (PCAR), CNH Industrial (CNHI), Navistar (NAV), Cummins (CMI) and Allison Transmission (ALSN).

08:32 EDT Berry Global announces 793 pence per RPC share bid as final offer - Berry Global's Berry Bidco announces that its recommended offer of 793 pence in cash per RPC share is declared final and will not be increased, except that Berry Bidco reserves the right to increase the amount of the consideration if there is an announcement on or after the date hereof of an offer or a possible offer for RPC by a third party offeror or potential offeror. "Berry Bidco has made good progress in relation to the Acquisition and confirms that all regulatory filings in relation to the Acquisition have been submitted to the relevant authorities. Berry Bidco's expectation is that the Acquisition will close early in the third quarter of 2019. RPC is expected to post the scheme document to RPC shareholders on Tuesday 26 March and to hold its shareholder meetings to approve the Acquisition on Thursday 18 April," the company stated.

08:08 EDT Cloud infrastructure provider selects Zayo for connectivity - A cloud infrastructure provider has selected Zayo Group Holdings for wavelength connectivity. The long-haul wavelength solution will connect a new data center for the company located on the West Coast.

08:04 EDT Vale says SEMAD allows return of operations at Brucutu mine - Vale S.A informs that, in addition to the press release "Vale updates on the Laranjeiras tailings dam" of March 19th, 2019, it received from the State Agency for Environment and Sustainable Development the Provisional Operational Authorization for the Laranjeiras dam, allowing the return of operations at the Brucutu mine in the next 72 hours. Additionally, Vale informs that the injunction decision of the 1st Civil Court of Nova Lima made today related to the Dique III dam will not have an additional impact on its production, given that the referred dam is located in the complex of Vargem Grande, which operations have already been halted by the National Mining Agency, as disclosed in the Press Release "Clarification on the Vargem Grande, Grupo and Forquilha I, II and III dams" of March 1st, 2019. Vale was not formally notified of the decision and will take the appropriate measures in due course.

08:03 EDT Palo Alto Networks: Traps product secures FedRAMP 'In Process' status - Palo Alto Networks announced its Traps endpoint protection and response product has achieved the designation of "In Process" for the Federal Risk and Authorization Management Program. This achievement marks an important milestone for Traps, which combines multiple methods of prevention to provide endpoint security.

07:49 EDT Archer Daniels creates sustainability and corporate responsibility committee - Archer Daniels Midland Company Board of Directors has nominated Dr. Lei Zhang Schlitz to stand for election to the board at the company's upcoming Annual Stockholders' Meeting on May 1, 2019. Schlitz has held a series of senior-level positions for Illinois Tool Works. Currently, she serves as executive vice president of ITW's Food Equipment segment. Daniel Shih, who has served as an ADM director since 2012, has informed the board that he will not seek re-election at the annual stockholders' meeting. The company also announced the creation of a new Board committee on Sustainability and Corporate Responsibility. The committee, which will be formally launched at the upcoming May 2019 Board meeting and chaired by Board member Suzan Harrison, will set strategic objectives, goals and strategies for the company's sustainability and corporate citizenship efforts.

07:20 EDT Sorrento Therapeutics subsidiary merges with Semnur Pharmaceuticals - Sorrento Therapeutics announced that its majority owned subsidiary Scilex Pharmaceuticals has closed a transaction to merge with Mountain View, California, based Semnur Pharmaceuticals to form a new company, Scilex Holding. Sorrento's equity stake in Scilex, 77%, has been converted into a 58% stake in Scilex Holding. With Scilex's lead product ZTlido ramping rapidly in the early months of commercial launch and Semnur's lead compound in Phase 3 pivotal studies for the treatment of lumbar radicular pain/sciatica with fast track status from the FDA.

07:01 EDT United Airlines offers non-binary gender options throughout all booking channels - United Airlines announced it has become the first U.S. airline to offer non-binary gender options throughout all booking channels in addition to providing the option to select the title "Mx." during booking and in a MileagePlus customer profile. Customers now have the ability to identify themselves as M(male), F(female), U(undisclosed) or X(unspecified), corresponding with what is indicated on their passports or identification. "United is determined to lead the industry in LGBT inclusivity, and we are so proud to be the first U.S. airline to offer these inclusive booking options for our customers," said United's Chief Customer Officer Toby Enqvist. "United is excited to share with our customers, whether they identify along the binary of male or female or not, that we are taking the steps to exhibit our care for them while also providing additional employee training to make us even more welcoming for all customers and employees."

06:53 EDT Genmab announces regulatory submission for daratumumab to EMA - Genmab (GMXAY) announced that Janssen (JNJ) has submitted a Type II variation application to the European Medicines Agency, or EMA. The application seeks to broaden the existing marketing authorization for daratumumab to include use in combination with lenalidomide and dexamethasone, or Rd, as treatment for newly diagnosed multiple myeloma patients who are not candidates for high dose chemotherapy and autologous stem cell transplant, or ASCT. The submission is based on data from the Phase III MAIA study of daratumumab in combination with Rd as treatment for patients with newly diagnosed multiple myeloma, who are not candidates for high dose chemotherapy and ASCT.

06:48 EDT VAALCO Energy CFO Phil Patman to resign, Elizabeth Prochnow to succeed - VAALCO Energy announced that Phil Patman, VAALCO's CFO, has elected to resign from the company, effective March 31, to pursue other interests. Elizabeth Prochnow, the company's Chief Accounting Officer, has been appointed by the Board to the role of CFO effective April 1. Patman's departure was not related to any issues regarding financial disclosures, accounting or legal matter. Prochnow has served as VAALCO's Chief Accounting Officer since joining the company in March 2015. Prochnow has held a variety of senior finance leadership positions including Executive Vice President, CFO of Sterling Construction Company, and Vice President, Finance and CFO of Bristow Group.

06:46 EDT Tiffany reports net inventories at January 31 were 8% above prior year - Primarily reflecting higher levels of finished goods inventories.

06:44 EDT Tiffany CEO: 'Softer trends in second half reflected external challenges' - Alessandro Bogliolo, CEO, said, "Our team is proud of its accomplishments in 2018 that contributed to net sales surpassing levels not seen since 2014. Softer trends in the second half of the year reflected, in part, what we believe were external challenges and uncertainties." He added, "Most important, we are still in the early stages of a journey to achieve long-term sales, margin and earnings growth for this legendary brand, and are making progress across our six key strategic priorities: Amplifying an evolved brand message; Renewing our product offerings and enhancing in-store presentations; Delivering an exciting omnichannel customer experience; Strengthening our competitive position and leading in key markets; Cultivating a more efficient operating model; and Inspiring an aligned and agile organization to win. I continue to strongly believe that Tiffany has vast global growth opportunities and we look forward to realizing our full potential in the future."

06:37 EDT Hibbett Sports sees approximately 10-15 new store openings in FY20 - Expectations for FY20: Approximately 10-15 new store openings with approximately 95 store closures. Decline in gross margin rate in the range of 25-45 basis points. Excluding non-recurring costs for both years, non-GAAP gross margin is expected to decline in the range of 35-55 basis points. Increase in SG&A expense rate in the range of 15-25 basis points. Excluding non-recurring costs for both years, approximately flat as a percentage of sales. Decline in depreciation expense in the range of 10-20 basis points. Tax rate of approximately 24.5%. Capital expenditures of approximately $18M-$22M. Share buyback of approximately $10M-$15M. Full repayment of $35M in debt related to the City Gear acquisition.

06:33 EDT Reven Housing announces review of strategic alternatives - Reven Housing announced that its board is conducting a review of strategic options focusing on maximizing shareholder value. The company has engaged RBC Capital to assist in this process. The company plans to explore a wide range of strategic alternatives that include, among others, a sale of the company, business combination, merger with another company, strategic investment/financing, or a funded collaboration or partnership which would allow the company to continue with its current business plan of buying and managing single-family residential properties throughout the southeast U.S. There can be no assurances that the exploration of strategic alternatives will result in any transaction. Reven does not intend to discuss or disclose developments with respect to the process unless and until otherwise determined that further disclosure is appropriate or required by regulation or law. No formalized timetable has been established for the completion of the strategic review.

06:31 EDT Hibbett Sports reports Q4 SSS up 3.8%

06:05 EDT Covanta, Green Investment Group reach financial close on Rookery project - Covanta and Green Investment Group announced that the Rookery South Energy Recovery Facility in Bedfordshire, England has reached financial close and will commence construction. Covanta and GIG will each own 40% of the state-of-the-art facility, with primary waste supplier Veolia ES Limited owning the remaining 20%. The Rookery facility will provide 545,000 tonnes of annual treatment capacity for non-recyclable waste, further enabling the UK to achieve national self-sufficiency in managing waste and compliance with landfill diversion targets. Veolia will deliver the majority of Rookery's waste supply under a long-term contract, with the balance of the waste sourced through other commercial, industrial and municipal counterparties. In processing this waste, Rookery will generate over 60 megawatts of electricity which will be sold into the grid on a merchant basis, powering the equivalent of over 112,500 homes.

05:24 EDT Eisai announces initiation of Phase III BAN2401 study in Alzheimer's disease - Eisai (ESALY) announced that a global Phase III clinical study of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer's disease has been initiated. BAN2401 is being jointly developed by Eisai and Biogen (BIIB). The "Clarity AD" is a global placebo-controlled, double-blind, parallel-group, randomized study in 1,566 patients with mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia with confirmed amyloid pathology in the brain. "After discussion with regulatory agencies based on the results of a Phase II clinical study, a single Phase III clinical study is being initiated to support a filing for BAN2401," Eisai said in a statement. The treatment group will be administered a dosage of 10 mg/kg bi-weekly of BAN2401, with patients allocated in a 1:1 ratio to receive either placebo or the treatment group. The primary endpoint is the change from baseline in the Clinical Dementia Rating-Sum of Boxes at 18 months of treatment. Respective changes from baseline to 18 months of treatment in the AD composite score, AD Assessment Scale-Cognitive Subscale, and brain amyloid levels as measured by amyloid positron emission tomography have been set as key secondary endpoints, the company said. It added, " Eisai aims to create innovative medicines for Alzheimer's disease as soon as possible in order to further contribute to addressing the unmet medical needs of, as well as potentially increasing the benefits provided to, patients and their families."